Micron to Add Surcharge on Memory Products Amid New U.S. Tariffs
Trump’s latest trade measures prompt Micron to pass on costs to customers starting Wednesday Micron Technology (NASDAQ: MU) has informed ...
Tag: News
U.S. Steel Shares Soar After Trump Orders Review of Blocked Nippon Deal
White House revisits $14.1 billion acquisition previously blocked over national security concerns Shares of U.S. Steel (NYSE: X) surged more ...
Nike, Lululemon Surge as Vietnam Signals Tariff Cuts After Trump Call
Vietnam Offers to Slash Tariffs to Avoid U.S. Levies, Boosting Apparel and Retail Stocks Shares of major apparel and footwear ...
Intel and TSMC to Form Joint Venture for U.S. Chipmaking
TSMC to Take 20% Stake as Intel Seeks to Boost Manufacturing Intel and Taiwan Semiconductor Manufacturing Co. (TSMC) have reached ...
Walmart and Costco Poised to Weather New Tariffs
Retail Giants Expected to Benefit as Shoppers Prioritize Essentials Retail giants Walmart (WMT) and Costco (COST) are well-positioned to navigate ...
Tesla’s Q1 Deliveries Drop Amid Stock Turmoil and Political Controversy
Elon Musk’s Political Ties, Factory Shutdowns, and Rising Competition Weigh on Performance Tesla’s vehicle deliveries declined in the first quarter ...
China’s Smart EV Leaders Post Strong Q1 Deliveries Amid Market Shifts
XPeng Leads Growth, While NIO and Li Auto Maintain Steady Gains China’s top three smart electric vehicle (EV) manufacturers—NIO Inc. ...
GM and Ford Post Strong Q1 Sales, but Tariff Fears Loom Over Auto Industry
General Motors (GM) and Ford (F) delivered strong first-quarter U.S. sales results, with GM reporting a 17% year-over-year increase to ...
Ideal Power Accelerates Market Entry with Early Completion of First B-TRAN Design Win
Successful Solid-State Circuit Breaker Prototypes Signal Growth Potential Ideal Power (IPWR) has reached a key milestone in its commercialization strategy, ...
Biotech Stocks Slide as FDA’s Peter Marks Resigns
Wall Street Reacts to Leadership Uncertainty in Biopharma Approvals The resignation of Peter Marks, director of the FDA’s Center for ...
